Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sentinel node imaging via a nonparticulate receptor-binding radiotracer

D R Vera1, E R Wisner, R C Stadalnik

  • 1Department of Radiology, University of California, Davis, USA.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|April 1, 1997
PubMed
Summary

A novel technetium-99m-labeled agent targets lymph nodes via receptor-mediated uptake, demonstrating effective lymph node scintigraphy. This nonparticulate imaging agent shows promise for enhanced diagnostic imaging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of a heart base tumor and chylothorax with endovascular stent, stereotactic body radiation therapy, and a tyrosine kinase inhibitor in a dog.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2021
Same author

Next generation of radiotracers for sentinel lymph node biopsy: What is still necessary to establish new imaging paradigms?

Revista espanola de medicina nuclear e imagen molecular·2018
Same author

Canine Nervous System Lymphoma Subtypes Display Characteristic Neuroanatomical Patterns.

Veterinary pathology·2016
Same author

Characterization of an Inherited Neurologic Syndrome in Toyger Cats with Forebrain Commissural Malformations, Ventriculomegaly and Interhemispheric Cysts.

Journal of veterinary internal medicine·2016
Same author

Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb.

Equine veterinary journal·2013
Same author

Scintigraphic evaluation of intra-arterial and intravenous regional limb perfusion of allogeneic bone marrow-derived mesenchymal stem cells in the normal equine distal limb using (99m) Tc-HMPAO.

Equine veterinary journal·2012

Area of Science:

  • Nuclear medicine
  • Radiopharmaceutical chemistry
  • Molecular imaging

Background:

  • Lymph node scintigraphy is crucial for diagnosing various conditions.
  • Current imaging agents may have limitations in specificity and uptake.
  • Targeting reticuloendothelial cells via receptor-mediated mechanisms offers a novel approach.

Purpose of the Study:

  • To synthesize and evaluate a novel technetium-99m-labeled agent for lymph node scintigraphy.
  • To assess the receptor-mediated uptake of the agent by reticuloendothelial cells.
  • To demonstrate the efficacy of this nonparticulate imaging agent in preclinical models.

Main Methods:

  • Synthesis of technetium-99m-labeled polydiethylenetriamine pentaacetic acid polymannosyl polylysine ([99mTc]DTPA-man-PL).

Related Experiment Videos

  • Subcutaneous administration in healthy rabbits, with imaging at various time points (1, 6, 12, 24 hours).
  • Quantification of injected dose in popliteal and axillary lymph nodes, including a control study with a non-specific agent.

    • Main Results:

    • Significant differences in 24-hour injected dose percentage were observed between the receptor-specific and non-specific agents in both popliteal and axillary nodes (p < 0.006 and p < 0.012, respectively).
    • [99mTc]DTPA-man-PL showed higher accumulation (3.00 +/- 0.72% in popliteal, 2.84 +/- 0.83% in axillary nodes at 24 hours) compared to the control ([99mTc]DTPA-polylysine: 0.13 +/- 0.08% and 0.22 +/- 0.12%).
    • Peak uptake for the specific agent occurred at 6 hours (4%), while the non-specific agent showed minimal accumulation (approx. 0.5%).

    Conclusions:

    • The study provides proof of principle for lymphoscintigraphy using receptor-mediated delivery.
    • The developed nonparticulate imaging agent demonstrates targeted uptake and effective lymph node visualization.
    • This approach holds potential for improved diagnostic accuracy in lymph node imaging.